Sentence examples similar to cost-effectiveness of the future from inspiring English sources

Cost-effectiveness estimates are highly dependent upon the case fatality in the absence of the vaccine, which suggests that the vaccine is likely to be significantly more cost effective among poorer populations and among those with less access to prompt medical care – suggesting also that poverty reduction programs would be expected to reduce the cost-effectiveness of the vaccine in the future.

It also suggests that poverty reduction programs, nutritional support programs and the introduction of health insurance programs for the poor, such as the ones recently introduced in Mexico would be expected to reduce the cost-effectiveness of the vaccine in the future.

The cost-effectiveness estimates are highly dependent upon the mortality in the absence of the vaccine, which suggests that the vaccine is likely to be significantly more cost-effective among poorer populations and among those with less access to prompt medical care – such that poverty reduction programs would be expected to reduce the future cost-effectiveness of the vaccine.

Health -and work-related benefits, as well as the cost-effectiveness of the intervention, will help to inform future occupational practice.

We do not have data on the cost-effectiveness of the program although this could be collected in future research.

This study, from a payer perspective, examined: (1) the cost-effectiveness of the new 2012 ACIP vaccine policy recommendation relative to the 1997 ACIP recommendation; (2) the cost-effectiveness of potential future pneumococcal vaccination policies; and (3) key assumptions that influence study results.

Cost-effectiveness of the implantable cardioverter defibrillator.

A more precise estimate of the incidence of eligible patients is therefore required to determine the cost-effectiveness of a future trial of out-of-hospital CPAP.

Including this potential benefit would diminish the cost-effectiveness of a future vaccine.

Our analysis methodology can be used to evaluate the cost-effectiveness of future trials of macronutrient supplementation to reduce the high early mortality rate among low BMI adults, utilizing contemporary commodity prices and historical health outcomes specific to a given population.

The results of such research will be needed to evaluate the cost-effectiveness of future interventions and inform policy decisions regarding resource allocation.